Notícias · Recifes

Study identifies new brain targets for individualized epilepsy treatment

Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy.

Admin Recifes 15/07/2026 2

Anion gap remains pragmatic target during diabetic ketoacidosis treatment and resolution

Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring as they receive insulin infusions and other medical interventions to bring their blood glucose and ketone levels back into balance.

Admin Recifes 15/07/2026 2

New drug unlocks elusive immune receptor, opening path toward motor neuron disease treatme

University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough that could lead to new treatments for neurodegenerative conditions like motor neuron disease (MND).

Admin Recifes 15/07/2026 2

New adenomyosis atlas reveals lesion-specific signals that may spare healthy uterine tissu

Researchers at the University of Liverpool have identified distinctive biological characteristics within adenomyosis lesions that could help pave the way for more targeted, less invasive treatments. The findings from a team based in Professor Dharani Hapangama's gynecology resear

Admin Recifes 15/07/2026 3

Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATR

Admin Recifes 15/07/2026 3

Genetic information helps predict the onset and progression of glaucoma

Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already occurred. Earlier detection through targeted screenin

Admin Recifes 15/07/2026 2

Researchers discover treatable cause of severe anemia associated with a cancer therapy

Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies. Their findings, published in the latest iss

Admin Recifes 15/07/2026 2

Brain tumor vaccine links mutation targeting to eight-year survival gains

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions

Admin Recifes 15/07/2026 2

Fibronectin pathway may drive Marfan aortic damage, opening new drug targets

A new study published in Nature Communications identifies a molecular signaling pathway that contributes to the development of life-threatening aortic aneurysms and dissections in Marfan syndrome, a genetic disorder affecting connective tissue. The findings provide new insight in

Admin Recifes 15/07/2026 2

Ultra-processed foods linked to higher levels of 'bad' fatty acids in blood, study suggest

Consumption of ultra-processed food (UPF) results in a distinct metabolic "signature" in the blood, associated with potentially adverse health conditions, suggests a new study by an international team of researchers. The paper, published in Critical Reviews in Food Science and Nu

Admin Recifes 15/07/2026 2

New heart disease mechanism revealed: Next-generation targeted therapy shows benefit acros

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an international research team, has identified a new molecular mechanism involved in hypertrophic cardiomyopathy, the most common inherited cardiovascular disea

Admin Recifes 15/07/2026 2

Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET

Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes